WO2025131978 - DRUG-LINKER REAGENTS FOR CONJUGATION
National phase entry is expected:
Publication Number
WO/2025/131978
Publication Date
26.06.2025
International Application No.
PCT/EP2024/085864
International Filing Date
12.12.2024
Title **
[English]
DRUG-LINKER REAGENTS FOR CONJUGATION
[French]
RÉACTIFS DE LIEUR DE MÉDICAMENT POUR CONJUGAISON
Applicants **
NERVIANO MEDICAL SCIENCES S.R.L.
Inventors
ORSINI, Paolo
SALSA, Matteo
Priority Data
23218555.3
20.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2047 | |
| EPO | Filing, Examination, Granting | 8747 | |
| Japan | Filing, Examination, Granting | 1956 | |
| South Korea | Filing, Examination, Granting | 1619 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,109
Contact Us
Abstract[English]
The present invention provides novel drug-linker reagent compounds of formula (I) designed to react with a suitable functional group of a carrier for the preparation of conjugates. Synthetic process for the preparation of such drug-linker reagents is also described.[French]
La présente invention concerne de nouveaux composés réactifs lieur-médicament de formule (I) conçus pour réagir avec un groupe fonctionnel approprié d'un véhicule pour la préparation de conjugués. L'invention concerne également un procédé de synthèse pour la préparation de tels réactifs lieur-médicament.